Related references
Note: Only part of the references are listed.Alternative activation of human macrophages enhances tissue factor expression and production of extracellular vesicles
Philipp J. Hohensinner et al.
HAEMATOLOGICA (2021)
Effects of Nicorandil on Inflammation, Apoptosis and Atherosclerotic Plaque Progression
Max Lenz et al.
BIOMEDICINES (2021)
Neutrophil Extracellular Trap Degradation by Differently Polarized Macrophage Subsets
Patrick Haider et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial
Roberto Ferrari et al.
LANCET (2020)
Atherosclerosis
Peter Libby et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Cell Type-Specific Roles of NF-κB Linking Inflammation and Thrombosis
Marion Mussbacher et al.
FRONTIERS IN IMMUNOLOGY (2019)
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
Karen V. Swanson et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Novel Role of IL (Interleukin)-1β in Neutrophil Extracellular Trap Formation and Abdominal Aortic Aneurysms
Akshaya K. Meher et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
Alena Grebe et al.
CIRCULATION RESEARCH (2018)
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
Paul M. Ridker et al.
LANCET (2018)
Trimetazidine Protects Against Atherosclerosis by Changing Energy Charge and Oxidative Stress
Shuzhan Zheng et al.
MEDICAL SCIENCE MONITOR (2018)
Interleukin-1 Beta as a Target for Atherosclerosis Therapy Biological Basis of CANTOS and Beyond
Peter Libby
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Macrophage Metabolism As Therapeutic Target for Cancer, Atherosclerosis, and Obesity
Xenia Geeraerts et al.
FRONTIERS IN IMMUNOLOGY (2017)
Trimetazidine prevents macrophage-mediated septic myocardial dysfunction via activation of the histone deacetylase sirtuin 1
Jing Chen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Age intrinsic loss of telomere protection via TRF1 reduction in endothelial cells
P. J. Hohensinner et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages
Jong-Seok Moon et al.
NATURE MEDICINE (2016)
Inflammasomes: mechanism of assembly, regulation and signalling
Petr Broz et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis
Annika Warnatsch et al.
SCIENCE (2015)
Elastin fragmentation inatheroscleroticmice leads to intraplaque neovascularization, plaque rupture, myocardial infarction, stroke, and sudden death
Carole Van der Donckt et al.
EUROPEAN HEART JOURNAL (2015)
Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling
Haitao Wen et al.
NATURE IMMUNOLOGY (2011)
Dose translation from animal to human studies revisited
Shannon Reagan-Shaw et al.
FASEB JOURNAL (2008)
A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: the ERGO (etomoxir for the recovery of glucose oxidation) study
Christian J. F. Holubarsch et al.
CLINICAL SCIENCE (2007)
Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease
GK Hansson
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Pneumococcal vaccination decreases atherosclerotic lesion formation:: molecular mimicry between Streptococcus pneumoniae and oxidized LDL
CJ Binder et al.
NATURE MEDICINE (2003)
Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene
MJH Nicklin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
